Thrower Edwin C, Diaz de Villalvilla Alexander P E, Kolodecik Thomas R, Gorelick Fred S
Veterans Administration Medical Center, Bldg. 27, 950 Campbell Avenue, West Haven, CT 06516, USA.
Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G894-902. doi: 10.1152/ajpgi.00373.2005. Epub 2005 Dec 8.
Pathological activation of digestive zymogens within the pancreatic acinar cell initiates acute pancreatitis. Cytosolic events regulate this activation within intracellular compartments of unclear identity. In an in vivo model of acute pancreatitis, zymogen activation was detected in both zymogen granule-enriched and microsomal cellular fractions. To examine the mechanism of this activation in vitro, a reconstituted system was developed using pancreatic cytosol, a zymogen granule-enriched fraction, and a microsomal fraction. Addition of cytosol to either particulate fraction resulted in a prominent increase in both trypsin and chymotrypsin activities. The percentage of the pool of trypsinogen and chymotrypsinogen activated was about twofold and sixfold greater, respectively, in the microsomal than in the zymogen granule-enriched fraction. Activation of chymotrypsinogen but not trypsinogen was significantly enhanced by ATP (5 mM) but not by the inactive ATP analog AMP-PNP. The processing of procarboxypeptidase B to its mature form also demonstrated a requirement for ATP and cytosol. E64d, an inhibitor of cathepsin B, a thiol protease that can activate trypsin, completely inhibited trypsin activity but did not affect chymotrypsin activity or carboxypeptidase B generation. These studies demonstrate that both zymogen granule-enriched and microsomal fractions from the pancreas can support cytosol-dependent zymogen activation. A component of the activation of some zymogens, such as chymotrypsinogen and procarboxypeptidase, may depend on ATP but not on trypsin or cathepsin B.
胰腺腺泡细胞内消化酶原的病理性激活引发急性胰腺炎。胞质内事件在身份不明的细胞内区室中调节这种激活。在急性胰腺炎的体内模型中,在富含酶原颗粒的细胞组分和微粒体组分中均检测到酶原激活。为了在体外研究这种激活的机制,利用胰腺胞质溶胶、富含酶原颗粒的组分和微粒体组分开发了一种重组系统。向任何一种颗粒组分中添加胞质溶胶都会导致胰蛋白酶和糜蛋白酶活性显著增加。微粒体中被激活的胰蛋白酶原和糜蛋白酶原的比例分别比富含酶原颗粒的组分中大约高两倍和六倍。ATP(5 mM)可显著增强糜蛋白酶原的激活,但无活性的ATP类似物AMP-PNP则不能。羧肽酶原B加工成其成熟形式也显示需要ATP和胞质溶胶。E64d是组织蛋白酶B(一种可激活胰蛋白酶的巯基蛋白酶)的抑制剂,它完全抑制胰蛋白酶活性,但不影响糜蛋白酶活性或羧肽酶B的生成。这些研究表明,胰腺中富含酶原颗粒的组分和微粒体组分均可支持胞质溶胶依赖性酶原激活。某些酶原(如糜蛋白酶原和羧肽酶原)激活的一个成分可能依赖于ATP,但不依赖于胰蛋白酶或组织蛋白酶B。